 Seth Septer
Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenomatous Polyposis Coli | 8 | 2022 | 39 | 2.700 |
Why?
| | Adenomatous Polyposis Coli Protein | 2 | 2018 | 20 | 1.080 |
Why?
| | Genetic Counseling | 2 | 2016 | 77 | 0.980 |
Why?
| | Hepatoblastoma | 3 | 2019 | 46 | 0.620 |
Why?
| | Dentofacial Deformities | 1 | 2018 | 1 | 0.580 |
Why?
| | Osteosclerosis | 1 | 2018 | 2 | 0.580 |
Why?
| | Osteoma | 1 | 2018 | 2 | 0.580 |
Why?
| | Mandibular Neoplasms | 1 | 2018 | 21 | 0.570 |
Why?
| | Intestinal Polyposis | 2 | 2019 | 7 | 0.560 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2016 | 228 | 0.550 |
Why?
| | Genetic Testing | 3 | 2019 | 462 | 0.550 |
Why?
| | Neoplastic Syndromes, Hereditary | 2 | 2019 | 44 | 0.540 |
Why?
| | Counselors | 1 | 2016 | 13 | 0.520 |
Why?
| | Genes, APC | 2 | 2019 | 12 | 0.520 |
Why?
| | Polyps | 1 | 2013 | 11 | 0.410 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2013 | 19 | 0.400 |
Why?
| | Esophageal Diseases | 1 | 2013 | 28 | 0.400 |
Why?
| | Liver Neoplasms | 2 | 2016 | 786 | 0.390 |
Why?
| | Esophagitis | 1 | 2013 | 67 | 0.390 |
Why?
| | Chromosome Deletion | 1 | 2013 | 115 | 0.390 |
Why?
| | Early Detection of Cancer | 1 | 2016 | 447 | 0.350 |
Why?
| | Mutation | 4 | 2018 | 3956 | 0.350 |
Why?
| | Esophagus | 1 | 2013 | 255 | 0.340 |
Why?
| | Barrett Esophagus | 1 | 2013 | 150 | 0.340 |
Why?
| | Phosphoproteins | 1 | 2011 | 338 | 0.310 |
Why?
| | Genetic Predisposition to Disease | 2 | 2015 | 2427 | 0.310 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2011 | 429 | 0.300 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1263 | 0.290 |
Why?
| | Liver | 2 | 2018 | 1943 | 0.280 |
Why?
| | Colectomy | 2 | 2016 | 100 | 0.210 |
Why?
| | Child | 13 | 2022 | 21985 | 0.200 |
Why?
| | Radiography, Panoramic | 2 | 2021 | 11 | 0.190 |
Why?
| | Child, Preschool | 6 | 2019 | 11106 | 0.180 |
Why?
| | Infant | 6 | 2016 | 9482 | 0.160 |
Why?
| | Colonoscopy | 3 | 2019 | 245 | 0.150 |
Why?
| | Cromolyn Sodium | 1 | 2018 | 11 | 0.150 |
Why?
| | Polycystic Kidney, Autosomal Recessive | 1 | 2018 | 6 | 0.150 |
Why?
| | Cell Degranulation | 1 | 2018 | 41 | 0.150 |
Why?
| | Colonic Polyps | 1 | 2019 | 88 | 0.140 |
Why?
| | Craniopharyngioma | 1 | 2019 | 74 | 0.140 |
Why?
| | Jaw | 1 | 2018 | 26 | 0.140 |
Why?
| | Pituitary Neoplasms | 1 | 2019 | 190 | 0.130 |
Why?
| | Cell Proliferation | 2 | 2017 | 2476 | 0.130 |
Why?
| | beta Catenin | 1 | 2019 | 253 | 0.130 |
Why?
| | Mast Cells | 1 | 2018 | 148 | 0.130 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2017 | 188 | 0.130 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2016 | 7 | 0.130 |
Why?
| | Polycystic Kidney Diseases | 1 | 2017 | 76 | 0.130 |
Why?
| | Duodenal Neoplasms | 1 | 2016 | 23 | 0.120 |
Why?
| | Adolescent | 7 | 2019 | 21558 | 0.120 |
Why?
| | Chemoprevention | 1 | 2016 | 92 | 0.120 |
Why?
| | Capsule Endoscopy | 1 | 2015 | 18 | 0.120 |
Why?
| | Prevalence | 2 | 2021 | 2731 | 0.110 |
Why?
| | Microbiota | 1 | 2022 | 762 | 0.110 |
Why?
| | Genetic Diseases, Inborn | 1 | 2014 | 44 | 0.110 |
Why?
| | Humans | 17 | 2022 | 137597 | 0.110 |
Why?
| | Lymphoproliferative Disorders | 1 | 2014 | 57 | 0.110 |
Why?
| | Male | 10 | 2019 | 67788 | 0.110 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2013 | 10 | 0.100 |
Why?
| | Failure to Thrive | 1 | 2013 | 29 | 0.100 |
Why?
| | STAT3 Transcription Factor | 1 | 2014 | 206 | 0.100 |
Why?
| | Pediatrics | 3 | 2019 | 1102 | 0.100 |
Why?
| | Stomach | 1 | 2013 | 110 | 0.100 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2013 | 71 | 0.100 |
Why?
| | Vomiting | 1 | 2013 | 130 | 0.100 |
Why?
| | Colorectal Neoplasms | 2 | 2019 | 808 | 0.090 |
Why?
| | Thyroid Neoplasms | 1 | 2016 | 325 | 0.090 |
Why?
| | Self Report | 1 | 2016 | 829 | 0.090 |
Why?
| | Female | 10 | 2019 | 73349 | 0.090 |
Why?
| | Gastritis | 1 | 2013 | 108 | 0.090 |
Why?
| | Ion Transport | 1 | 2011 | 60 | 0.090 |
Why?
| | Abdominal Pain | 1 | 2013 | 145 | 0.090 |
Why?
| | PTEN Phosphohydrolase | 1 | 2013 | 167 | 0.090 |
Why?
| | Treatment Outcome | 3 | 2016 | 10821 | 0.090 |
Why?
| | Phenotype | 3 | 2019 | 3200 | 0.090 |
Why?
| | Deglutition Disorders | 1 | 2013 | 140 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2017 | 1097 | 0.090 |
Why?
| | Tretinoin | 1 | 2011 | 123 | 0.090 |
Why?
| | Cell Cycle Proteins | 2 | 2011 | 616 | 0.090 |
Why?
| | Organ Size | 1 | 2011 | 477 | 0.090 |
Why?
| | Autoimmune Diseases | 1 | 2014 | 460 | 0.080 |
Why?
| | Collagen | 1 | 2013 | 452 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 282 | 0.080 |
Why?
| | Mass Screening | 1 | 2019 | 1288 | 0.080 |
Why?
| | Bile Acids and Salts | 1 | 2011 | 200 | 0.080 |
Why?
| | Kidney | 1 | 2018 | 1475 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2018 | 3567 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2019 | 15619 | 0.080 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2011 | 362 | 0.070 |
Why?
| | Optic Neuritis | 1 | 2008 | 41 | 0.070 |
Why?
| | Bronchiolitis | 1 | 2008 | 80 | 0.070 |
Why?
| | Pneumonia, Bacterial | 1 | 2008 | 116 | 0.070 |
Why?
| | Feeding and Eating Disorders | 1 | 2008 | 152 | 0.060 |
Why?
| | Mice, Inbred C57BL | 2 | 2017 | 5764 | 0.060 |
Why?
| | Biopsy | 2 | 2022 | 1125 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1768 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2011 | 1993 | 0.050 |
Why?
| | Apoptosis | 1 | 2011 | 2554 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 2487 | 0.050 |
Why?
| | Adult | 4 | 2021 | 37937 | 0.050 |
Why?
| | Clinical Competence | 1 | 2008 | 1127 | 0.040 |
Why?
| | Young Adult | 2 | 2013 | 13223 | 0.040 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2019 | 77 | 0.040 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2019 | 133 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 676 | 0.040 |
Why?
| | Point Mutation | 1 | 2019 | 235 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 172 | 0.040 |
Why?
| | Connective Tissue Growth Factor | 1 | 2017 | 25 | 0.030 |
Why?
| | Animals | 3 | 2018 | 36935 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2018 | 4287 | 0.030 |
Why?
| | Age Factors | 2 | 2015 | 3297 | 0.030 |
Why?
| | Gastroenterology | 1 | 2019 | 180 | 0.030 |
Why?
| | Adenoma | 1 | 2019 | 230 | 0.030 |
Why?
| | Consensus | 1 | 2019 | 683 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 469 | 0.030 |
Why?
| | Electronic Mail | 1 | 2015 | 64 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2022 | 2859 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2019 | 740 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2014 | 58 | 0.030 |
Why?
| | STAT1 Transcription Factor | 1 | 2014 | 72 | 0.030 |
Why?
| | Mice | 1 | 2011 | 17789 | 0.030 |
Why?
| | Canada | 1 | 2015 | 410 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2015 | 565 | 0.030 |
Why?
| | Dyspepsia | 1 | 2013 | 10 | 0.030 |
Why?
| | Needs Assessment | 1 | 2015 | 375 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 1061 | 0.030 |
Why?
| | Gastric Mucosa | 1 | 2013 | 55 | 0.030 |
Why?
| | Gene Expression | 1 | 2017 | 1503 | 0.020 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2013 | 58 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2753 | 0.020 |
Why?
| | Fellowships and Scholarships | 1 | 2015 | 307 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2011 | 56 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2014 | 389 | 0.020 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2011 | 78 | 0.020 |
Why?
| | Gene Silencing | 1 | 2011 | 194 | 0.020 |
Why?
| | Cholangiocarcinoma | 1 | 2011 | 104 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3018 | 0.020 |
Why?
| | Bile Duct Neoplasms | 1 | 2011 | 124 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5467 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1760 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1067 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4193 | 0.020 |
Why?
| | Cell Communication | 1 | 2011 | 315 | 0.020 |
Why?
| | Curriculum | 1 | 2015 | 996 | 0.020 |
Why?
| | Moraxellaceae Infections | 1 | 2008 | 3 | 0.020 |
Why?
| | Cell Survival | 1 | 2011 | 1120 | 0.020 |
Why?
| | Sampling Studies | 1 | 2008 | 98 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 2040 | 0.020 |
Why?
| | Chronic Disease | 1 | 2013 | 1794 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2011 | 708 | 0.020 |
Why?
| | Internship and Residency | 1 | 2015 | 1151 | 0.010 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 565 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3407 | 0.010 |
Why?
| | Transcription Factors | 1 | 2011 | 1720 | 0.010 |
Why?
| | United States | 1 | 2015 | 14868 | 0.010 |
Why?
| | Signal Transduction | 1 | 2011 | 5084 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2008 | 1809 | 0.010 |
Why?
|
|
Septer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|